Cargando…
The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence
BACKGROUND: Pharmacokinetic (PK) data underlying paediatric penicillin dosing remain limited, especially in critical care. OBJECTIVES: The primary objective of the Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA) was to characterize PK profiles of commonly used penicillins us...
Autores principales: | Barker, Charlotte I S, Kipper, Karin, Lonsdale, Dagan O, Wright, Kirstie, Thompson, Georgina, Kim, Min, Turner, Mark A, Johnston, Atholl, Sharland, Mike, Standing, Joseph F |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477139/ https://www.ncbi.nlm.nih.gov/pubmed/37531085 http://dx.doi.org/10.1093/jac/dkad196 |
Ejemplares similares
-
Population Pharmacokinetic Study of Benzylpenicillin in Critically Unwell Adults
por: Shah, Reya V., et al.
Publicado: (2023) -
Scaling clearance in paediatric pharmacokinetics: All models are wrong, which are useful?
por: Germovsek, Eva, et al.
Publicado: (2016) -
Pharmacokinetic–pharmacodynamic cutoff values for benzylpenicillin in horses to support the establishment of clinical breakpoints for benzylpenicillin antimicrobial susceptibility testing in horses
por: Lallemand, Elodie A., et al.
Publicado: (2023) -
Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
por: Germovsek, Eva, et al.
Publicado: (2018) -
Correction to: Pharmacokinetic–Pharmacodynamic Modeling in Pediatric Drug Development, and the Importance of Standardized Scaling of Clearance
por: Germovsek, Eva, et al.
Publicado: (2018)